表紙
市場調査レポート

経カテーテル大動脈弁置換術 (TAVR) の世界市場 (2016〜2020年)

Global Transcatheter Aortic Valve Replacement Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 350527
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
経カテーテル大動脈弁置換術 (TAVR) の世界市場 (2016〜2020年) Global Transcatheter Aortic Valve Replacement Market 2016-2020
出版日: 2016年01月20日 ページ情報: 英文 49 Pages
概要

経カテーテル大動脈弁置換術 (TAVR) 用装置とは、損傷した大動脈弁を除去せずに修復できる心血管装置で、大動脈弁逆流や大動脈弁狭窄症、大動脈弁変性といった大動脈弁の疾患の治療に用いられています。TAVRの処置方法には、経大腿アプローチ (大腿動脈経由) と経心尖アプローチ (胸部の小切開による) の2種類があります。世界のTAVR市場は2016〜2020年にかけて、16.9%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、世界の経カテーテル大動脈弁置換術 (以下TAVR) 市場について分析し、市場の概要や構造、市場規模の動向 (今後5年間の予測値)、製品別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・推計しております。

第1章 エグゼクティブ・サマリー

  • 分析結果の概略

第2章 分析範囲

  • 分析概要
  • 大手ベンダーの主要製品・サービス

第3章 市場分析の手法

  • 分析手法
  • 経済指標

第4章 イントロダクション

  • 市場動向の概略

第5章 市場環境

  • 市場概要
  • 市場規模とその予測
  • ファイブフォース分析

第6章 TAVR関連の治験の分析

第7章 コスト分析

  • 経カテーテル大動脈弁置換処置のコスト分析

第8章 製品別の市場区分

  • 経大腿埋め込みアプローチ
  • 経心尖埋め込みアプローチ

第9章 地域区分

  • 世界のTAVR市場:地域別の詳細動向 (今後6年間分)
  • 欧州・中東・アフリカ諸国 (EMEA) 市場
  • 南北アメリカ市場
  • アジア太平洋地域市場

第10章 米国のTAVR市場

第11章 市場促進要因

  • 高齢者人口の増加に伴う、大動脈弁狭窄症の有病者数の増加
  • 米国・日本での新たな経カテーテル弁埋め込み法の登場
  • 低侵襲性 (MI) 処置の普及

第12章 促進要因の影響力

第13章 市場の課題

  • 合併症の潜在的なリスク
  • 外科手術式の弁埋め込み処置との競合・脅威
  • 厳格な規制
  • 熟練した専門医の不足

第14章 促進要因・課題の影響力

第15章 市場の動向

  • 治験に対する関心
  • TAVR技術および自己拡張式ステントフレームの開発
  • 若年層・低リスク患者向け装置

第16章 ベンダー環境

  • 競争シナリオ
  • 主要ベンダー分析
  • その他の有力ベンダー

第17章 付録

  • 略語集

第18章 Technavioについて

図表一覧

目次
Product Code: IRTNTR8085

About Transcatheter Aortic Valve Replacement

Transcatheter heart valve replacement systems are cardiovascular devices that repair the aortic valve without removing the old and damaged valves. It is used to treat aortic valve disorders such as regurgitation, aortic stenosis, and degeneration. TAVI is performed in two ways, transfemoral approach (through the femoral artery) and transapical approach (through a small chest incision).

Technavio's analysts forecast the global TAVR market to grow at a CAGR of 16.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global TAVR market for the period 2015-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valve implants.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Transcatheter Aortic Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Edwards Lifesciences
  • Medtronic
  • Boston Scientific
  • St. Jude Medical

Other Prominent Vendors

  • Direct Flow Medical
  • JenaValve Technology
  • Meril Life Sciences
  • Sorin
  • SYMETIS

Market driver

  • Rise in prevalence of aortic stenosis with increase in aging population
  • For a full, detailed list, view our report

Market challenge

  • Risk of potential complications
  • For a full, detailed list, view our report

Market trend

  • Focus on clinical trials
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Clinical trial studies on TAVR

PART 07: Cost analysis

  • Cost analysis of aortic valve replacement procedures

PART 08: Market segmentation by product

  • Transfemoral implantation
  • Transapical implantation

PART 09: Geographical segmentation

  • Global TAVR market by geography 2015-2020
  • TAVR market in EMEA
  • TAVR market in Americas
  • TAVR market in APAC

PART 10: TAVR market in US

  • TAVR market in the US

PART 11: Market drivers

  • Rise in prevalence of aortic stenosis with increase in aging population
  • Launch of novel transcatheter valve implants in US and Japan
  • Increase in adoption of MI procedures

PART 12: Impact of drivers

PART 13: Market challenges

  • Risk of potential complications
  • Threat from surgical valve implant procedures
  • Stringent regulations
  • Lack of of skilled practitioners

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Focus on clinical trials
  • Development of TAVR technology and self-expandable stent frame
  • Devices for a younger and lower-risk patient population

PART 16: Vendor landscape

  • Competitive scenario
  • Key vendor analysis
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviation

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global TAVR market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Snapshot of TAVR device studies in clinical trials
  • Exhibit 05: Comparison of the cost involved in valve replacement procedures (high risk group)
  • Exhibit 06: Segmentation of TAVR market by product
  • Exhibit 07: Comparison of transfemoral and transapical implantation approaches
  • Exhibit 08: Global TAVR market by geography 2015
  • Exhibit 09: Global TAVR market by geography 2020
  • Exhibit 10: Segmentation global TAVR market by geography 2015-2020
  • Exhibit 11: TAVR market in EMEA 2015-2020 ($ millions)
  • Exhibit 12: TAVR market in Americas 2015-2020 ($ millions)
  • Exhibit 13: TAVR market in APAC 2015-2020 ($ millions)
  • Exhibit 14: TAVR market in US 2015-2020 ($ millions)
  • Exhibit 15: Pipeline snapshot of TAVR in US
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: TAVR systems with FDA approval 2011-2015
  • Exhibit 19: TAVR systems with CE mark approval 2007-2015
  • Exhibit 20: Product portfolio matrix for key vendors 2015
  • Exhibit 21: Market share analysis 2015
  • Exhibit 22: Edwards Lifesciences: Key takeaways
  • Exhibit 23: Medtronic: Key takeaways
  • Exhibit 24: Boston Scientific: Key takeaways
  • Exhibit 25: St. Jude Medical: Key takeaways
Back to Top